Joseph C. Wu
Clinical trials sponsored by Joseph C. Wu, explained in plain language.
-
Malaria drug artesunate tested for rare lung condition
Disease control Recruiting nowThis early-stage study is testing whether artesunate, a drug used for malaria, is safe for people with pulmonary arterial hypertension (PAH). Fifteen adults with PAH will take increasing doses of artesunate capsules for 20 weeks. The main goal is to check for side effects, not ye…
Phase: PHASE1 • Sponsor: Joseph C. Wu • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Malaria drug artesunate tested for lung scarring
Disease control Recruiting nowThis early-stage trial tests whether artesunate, a drug used for malaria, is safe for people with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. Fifteen adults with IPF will receive either artesunate capsules or a placebo for 12 week…
Phase: PHASE1 • Sponsor: Joseph C. Wu • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Stem cells injected into damaged hearts: a new hope?
Disease control Recruiting nowThis early-phase study tests whether injecting lab-grown heart cells (made from human embryonic stem cells) can safely improve heart function in 18 adults with chronic heart damage from a past heart attack. Participants receive one of three doses via a catheter, and researchers m…
Phase: PHASE1 • Sponsor: Joseph C. Wu • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC